89 related articles for article (PubMed ID: 1416757)
21. Migration of pump for intrathecal drug delivery into the peritoneal cavity. Case report.
Vanhauwaert DJ; Kalala JP; Baert E; Hallaert G; Crombez E; Caemaert J; Van Roost D
Surg Neurol; 2009 May; 71(5):610-2; discussion 612. PubMed ID: 18291481
[TBL] [Abstract][Full Text] [Related]
22. Patient management of long-term continuous subcutaneous insulin infusion.
Johansson UB; Adamson U; Lins PE; Wredling R
J Adv Nurs; 2005 Jul; 51(2):112-8. PubMed ID: 15963182
[TBL] [Abstract][Full Text] [Related]
23. An outpatient technique for continuous subcutaneous insulin infusion in adolescents and young adults with IDDM.
Strickland AL; Strickland J
J S C Med Assoc; 2000 Sep; 96(9):386-9. PubMed ID: 11043015
[No Abstract] [Full Text] [Related]
24. Intraperitoneal delivery of insulin via mechanical pump: surgical implications.
Udelsman R; Boyne MS; Loman KE; Saudek CD
Langenbecks Arch Surg; 2000 Oct; 385(6):367-72. PubMed ID: 11127519
[TBL] [Abstract][Full Text] [Related]
25. Multicentre trial of a programmable implantable insulin pump in type I diabetes. The Point Study II Group.
Int J Artif Organs; 1995 Jun; 18(6):322-5. PubMed ID: 8593967
[TBL] [Abstract][Full Text] [Related]
26. Surgical experience with implantable insulin pumps. Department of Veterans Affairs Implantable Insulin Pump Study Group.
Thompson JS; Duckworth WC; Saudek CD; Giobbie-Hurder A
Am J Surg; 1998 Dec; 176(6):622-6. PubMed ID: 9926802
[TBL] [Abstract][Full Text] [Related]
27. Macrophage activation in type 1 diabetic patients with catheter obstruction during peritoneal insulin delivery with an implantable pump.
Kessler L; Tritschler S; Bohbot A; Sigrist S; Karsten V; Boivin S; Dufour P; Belcourt A; Pinget M
Diabetes Care; 2001 Feb; 24(2):302-7. PubMed ID: 11213883
[TBL] [Abstract][Full Text] [Related]
28. Long-term implantation of a new implantable programmable insulin pump in two diabetic dogs.
Scavini M; Day PW; Eaton RP
Artif Organs; 1992 Oct; 16(5):518-22. PubMed ID: 10078304
[TBL] [Abstract][Full Text] [Related]
29. Complications of the pump pocket may represent a significant cause of incidents with implanted systems for intraperitoneal insulin delivery.
Renard E; Bringer J; Jacques-Apostol D; Lauton D; Mestre C; Costalat G; Jaffiol C
Diabetes Care; 1994 Sep; 17(9):1064-6. PubMed ID: 7988309
[TBL] [Abstract][Full Text] [Related]
30. Catheter complications associated with implantable systems for peritoneal insulin delivery. An analysis of frequency, predisposing factors, and obstructing materials.
Renard E; Baldet P; Picot MC; Jacques-Apostol D; Lauton D; Costalat G; Bringer J; Jaffiol C
Diabetes Care; 1995 Mar; 18(3):300-6. PubMed ID: 7555471
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic procedures for catheter malfunction in programmable implantable intraperitoneal insulin infusion devices.
Olsen CL; Turner DS; Iravani M; Waxman K; Selam JL; Charles MA
Diabetes Care; 1995 Jan; 18(1):70-6. PubMed ID: 7698051
[TBL] [Abstract][Full Text] [Related]
32. [Implantable insulin pump: the first step towards an artificial pancreas].
Vix M; Mutter D; Jeandidier N; Boivin S; Pinget M; Marescaux J
Ann Chir; 1994; 48(11):991-7. PubMed ID: 7733607
[TBL] [Abstract][Full Text] [Related]
33. [Diabetic radiculopathy].
Sühler K; Parhofer K; Richter WO; Witt TN; Schwandt P
Dtsch Med Wochenschr; 1990 Nov; 115(44):1665-9. PubMed ID: 2146105
[TBL] [Abstract][Full Text] [Related]
34. Successful pregnancy in I.D.D.M. with intravenous programmable insulin pump.
Brosnan E; Devlin JG
Ir J Med Sci; 1994 Feb; 163(2):56-7. PubMed ID: 8200770
[TBL] [Abstract][Full Text] [Related]
35. The programmable implantable medication system (PIMS): design features and pre-clinical trials.
Saudek CD; Fischell RE; Swindle MM
Horm Metab Res; 1990 Apr; 22(4):201-6. PubMed ID: 2190901
[TBL] [Abstract][Full Text] [Related]
36. Autoimmunity and intraperitoneal insulin treatment by programmable pumps: lack of relationship.
Lassmann-Vague V; SanMarco M; LeJeune PJ; Alessis C; Vague P; Belicar P
Diabetes Care; 1998 Nov; 21(11):2041-4. PubMed ID: 9802775
[No Abstract] [Full Text] [Related]
37. Experience of long-term intraperitoneal insulin treatment using a new percutaneous access device.
Wredling R; Adamson U; Lins PE; Backman L; Lundgren D
Diabet Med; 1991 Jul; 8(6):597-600. PubMed ID: 1832367
[TBL] [Abstract][Full Text] [Related]
38. Insulin delivery by implanted pumps: one-year trial with programmable infusion systems (the Point Study).
Walter H
Int J Artif Organs; 1989 Dec; 12(12):793-8. PubMed ID: 2693370
[TBL] [Abstract][Full Text] [Related]
39. Surgical aspects and complications of continuous intraperitoneal insulin infusion with an implantable pump.
Haveman JW; Logtenberg SJ; Kleefstra N; Groenier KH; Bilo HJ; Blomme AM
Langenbecks Arch Surg; 2010 Jan; 395(1):65-71. PubMed ID: 19048281
[TBL] [Abstract][Full Text] [Related]
40. Technical note: radiological insertion of an implantable drug delivery system.
Lopez AJ; Sidhu PS; Dutka D; Cousins C
Br J Radiol; 1994 May; 67(797):491-3. PubMed ID: 8193897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
